Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
麻豆原创 Analysis and Insights: Global Bacteriophage 麻豆原创
The global Bacteriophage market is projected to grow from US$ 43 million in 2024 to US$ 121.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 18.8% during the forecast period.
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
Report Covers:
This report presents an overview of global market for Bacteriophage market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bacteriophage, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bacteriophage, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bacteriophage revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Bacteriophage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Bacteriophage revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bacteriophage in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bacteriophage 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Bacteriophage 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage 麻豆原创 Perspective (2019-2030)
2.2 Global Bacteriophage Growth Trends by Region
2.2.1 Bacteriophage 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bacteriophage Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Bacteriophage Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Bacteriophage 麻豆原创 Dynamics
2.3.1 Bacteriophage Industry Trends
2.3.2 Bacteriophage 麻豆原创 Drivers
2.3.3 Bacteriophage 麻豆原创 Challenges
2.3.4 Bacteriophage 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bacteriophage by Players
3.1.1 Global Bacteriophage Revenue by Players (2019-2024)
3.1.2 Global Bacteriophage Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Bacteriophage 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bacteriophage, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Bacteriophage 麻豆原创 Concentration Ratio
3.4.1 Global Bacteriophage 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Revenue in 2023
3.5 Global Key Players of Bacteriophage Head office and Area Served
3.6 Global Key Players of Bacteriophage, Product and Application
3.7 Global Key Players of Bacteriophage, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Breakdown Data by Type
4.1 Global Bacteriophage Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Bacteriophage Forecasted 麻豆原创 Size by Type (2025-2030)
5 Bacteriophage Breakdown Data by Application
5.1 Global Bacteriophage Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Bacteriophage Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Bacteriophage 麻豆原创 Size (2019-2030)
6.2 North America Bacteriophage 麻豆原创 Size by Type
6.2.1 North America Bacteriophage 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Bacteriophage 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Bacteriophage 麻豆原创 Share by Type (2019-2030)
6.3 North America Bacteriophage 麻豆原创 Size by Application
6.3.1 North America Bacteriophage 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Bacteriophage 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Bacteriophage 麻豆原创 Share by Application (2019-2030)
6.4 North America Bacteriophage 麻豆原创 Size by Country
6.4.1 North America Bacteriophage 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Bacteriophage 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Bacteriophage 麻豆原创 Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Bacteriophage 麻豆原创 Size (2019-2030)
7.2 Europe Bacteriophage 麻豆原创 Size by Type
7.2.1 Europe Bacteriophage 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Bacteriophage 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Bacteriophage 麻豆原创 Share by Type (2019-2030)
7.3 Europe Bacteriophage 麻豆原创 Size by Application
7.3.1 Europe Bacteriophage 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Bacteriophage 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Bacteriophage 麻豆原创 Share by Application (2019-2030)
7.4 Europe Bacteriophage 麻豆原创 Size by Country
7.4.1 Europe Bacteriophage 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Bacteriophage 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Bacteriophage 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bacteriophage 麻豆原创 Size (2019-2030)
8.2 China Bacteriophage 麻豆原创 Size by Type
8.2.1 China Bacteriophage 麻豆原创 Size by Type (2019-2024)
8.2.2 China Bacteriophage 麻豆原创 Size by Type (2025-2030)
8.2.3 China Bacteriophage 麻豆原创 Share by Type (2019-2030)
8.3 China Bacteriophage 麻豆原创 Size by Application
8.3.1 China Bacteriophage 麻豆原创 Size by Application (2019-2024)
8.3.2 China Bacteriophage 麻豆原创 Size by Application (2025-2030)
8.3.3 China Bacteriophage 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bacteriophage 麻豆原创 Size (2019-2030)
9.2 Asia Bacteriophage 麻豆原创 Size by Type
9.2.1 Asia Bacteriophage 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Bacteriophage 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Bacteriophage 麻豆原创 Share by Type (2019-2030)
9.3 Asia Bacteriophage 麻豆原创 Size by Application
9.3.1 Asia Bacteriophage 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Bacteriophage 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Bacteriophage 麻豆原创 Share by Application (2019-2030)
9.4 Asia Bacteriophage 麻豆原创 Size by Region
9.4.1 Asia Bacteriophage 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Bacteriophage 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Bacteriophage 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Bacteriophage 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Details
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Bacteriophage Introduction
11.1.4 NPO Microgen Revenue in Bacteriophage Business (2019-2024)
11.1.5 NPO Microgen Recent Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Details
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Bacteriophage Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2019-2024)
11.2.5 Proteon Pharmaceuticals Recent Developments
11.3 Phagelux
11.3.1 Phagelux Company Details
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Bacteriophage Introduction
11.3.4 Phagelux Revenue in Bacteriophage Business (2019-2024)
11.3.5 Phagelux Recent Developments
11.4 Intralytix
11.4.1 Intralytix Company Details
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Bacteriophage Introduction
11.4.4 Intralytix Revenue in Bacteriophage Business (2019-2024)
11.4.5 Intralytix Recent Developments
11.5 Micreos
11.5.1 Micreos Company Details
11.5.2 Micreos Business Overview
11.5.3 Micreos Bacteriophage Introduction
11.5.4 Micreos Revenue in Bacteriophage Business (2019-2024)
11.5.5 Micreos Recent Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Details
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Bacteriophage Introduction
11.6.4 Eliava BioPreparations Revenue in Bacteriophage Business (2019-2024)
11.6.5 Eliava BioPreparations Recent Developments
11.7 Locus Biosciences, Inc
11.7.1 Locus Biosciences, Inc Company Details
11.7.2 Locus Biosciences, Inc Business Overview
11.7.3 Locus Biosciences, Inc Bacteriophage Introduction
11.7.4 Locus Biosciences, Inc Revenue in Bacteriophage Business (2019-2024)
11.7.5 Locus Biosciences, Inc Recent Developments
11.8 Pharmex Group, LLC
11.8.1 Pharmex Group, LLC Company Details
11.8.2 Pharmex Group, LLC Business Overview
11.8.3 Pharmex Group, LLC Bacteriophage Introduction
11.8.4 Pharmex Group, LLC Revenue in Bacteriophage Business (2019-2024)
11.8.5 Pharmex Group, LLC Recent Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Details
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Bacteriophage Introduction
11.9.4 Pherecydes Pharma Revenue in Bacteriophage Business (2019-2024)
11.9.5 Pherecydes Pharma Recent Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Details
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2019-2024)
11.10.5 APS Biocontrol Ltd. (APS) Recent Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Details
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2019-2024)
11.11.5 Qingdao Phagepharm Bio-tech Recent Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Details
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Bacteriophage Introduction
11.12.4 Fixed-Phage Limited Revenue in Bacteriophage Business (2019-2024)
11.12.5 Fixed-Phage Limited Recent Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Details
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Bacteriophage Introduction
11.13.4 Zeptometrix Revenue in Bacteriophage Business (2019-2024)
11.13.5 Zeptometrix Recent Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Details
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Bacteriophage Introduction
11.14.4 Phage International, Inc. Revenue in Bacteriophage Business (2019-2024)
11.14.5 Phage International, Inc. Recent Developments
11.15 MicroMir
11.15.1 MicroMir Company Details
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Bacteriophage Introduction
11.15.4 MicroMir Revenue in Bacteriophage Business (2019-2024)
11.15.5 MicroMir Recent Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Details
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Bacteriophage Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Bacteriophage Business (2019-2024)
11.16.5 iNtODEWORLD, Inc. Recent Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Details
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Bacteriophage Introduction
11.17.4 NEXTBIOTICS Revenue in Bacteriophage Business (2019-2024)
11.17.5 NEXTBIOTICS Recent Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Details
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2019-2024)
11.18.5 Armata Pharmaceuticals, Inc. Recent Developments
11.19 Innophage
11.19.1 Innophage Company Details
11.19.2 Innophage Business Overview
11.19.3 Innophage Bacteriophage Introduction
11.19.4 Innophage Revenue in Bacteriophage Business (2019-2024)
11.19.5 Innophage Recent Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Details
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Bacteriophage Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Bacteriophage Business (2019-2024)
11.20.5 Adaptive Phage Therapeutics Recent Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Details
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Bacteriophage Introduction
11.21.4 TechnoPhage Revenue in Bacteriophage Business (2019-2024)
11.21.5 TechnoPhage Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
听
听
*If Applicable.